№ files_lp_3_process_7_086871
Year: 2024
Region / City: UK
Subject: Type 2 Diabetes, Tirzepatide
Document Type: Medication Guidelines
Organization: LSCMMG
Author: Not specified
Target Audience: Clinicians prescribing medication for Type 2 Diabetes
Effective Period: From 12/09/2024
Approval Date: Not specified
Modification Date: Not specified
Link to NICE TA924: https://www.nice.org.uk/guidance/ta924/chapter/1-Recommendations
Link to SPC: https://www.medicines.org.uk/emc/product/15481/smpc
Link to Patient Information Leaflet: https://www.medicines.org.uk/emc/files/pil.15484.pdf
Link to Instructions for Use: https://www.medicines.org.uk/emc/files/usermanual.15484.pdf
Link to UK Medicines Information: https://www.sps.nhs.uk/articles/prescribing-available-glp-1-receptor-agonists/
Context: A guideline document detailing the prescription and dosing information for Tirzepatide (Mounjaro®) in the treatment of Type 2 Diabetes, with emphasis on administration, monitoring, and local prescribing restrictions.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.